9 Recruiting Studies Using Rituximab And Hyaluronidase Human
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Rituximab And Hyaluronidase Human
Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Mantle Cell Lymphoma
View Study & Checklist ➔Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
📍 Banner University Medical Center - Tucson — Tucson, Arizona
Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy
📍 Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia
Cutaneous Melanoma, Stage III
View Study & Checklist ➔Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Primary Mediastinal Large B-Cell Lymphoma
View Study & Checklist ➔An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment
📍 Sidney Kimmel Cancer Center at Thomas Jefferson University — Philadelphia, Pennsylvania
Recurrent B-Cell Non-Hodgkin Lymphoma
View Study & Checklist ➔Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma
📍 Mount Sinai Hospital — New York, New York
Mantle Cell Lymphoma
View Study & Checklist ➔Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Classic Follicular Lymphoma
View Study & Checklist ➔Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Nodular Lymphocyte Predominant B-Cell Lymphoma
View Study & Checklist ➔